PubMed COVID-19 Clinical Care

No abstract

No abstract

CONCLUSIONS: Our findings indicate that NMV-r to treat COVID-19 could reduce all-cause hospitalization and death in patients with CVDs.

CONCLUSIONS: Using retrospective claims data, pediatric index transmission of SARS-CoV-2 during the initial waves of SARS-CoV-2 in the U.S. is associated with location and family characteristics. Pediatric SAR (0-25 years) was less than SAR for all

Prolonged symptoms that occur after COVID-19 (long-COVID) vary from mild, which do not interfere with daily life, to severe, which require long-term social support. This study assessed the secular trend in online searches on long-COVID in Japan. We

The COVID-19 pandemic vaccination infrastructure was redeployed to address the Mpox epidemic. The Westchester County Department of Health coordinated an effective vaccine distribution, tracking, and data collection process with community partners

Chronic kidney disease (CKD) patients are at higher risk of severe COVID-19. Humoral and cellular immunity from prior infection or vaccination are important for protection, but the neutralizing antibody (nAb) response against SARS-CoV-2 variants is

Tubercuiosis is still a significant problem worldwide. Until the COVID-19 pandemic, tuberculosis was the leading cause of mortality from a single infectious agent. Pulmonary Tubercuiosis patients are more tending to be co-infected with COVID-19

No abstract

This study presents novel methodology for pandemic risks assessment for a national health system of interest. The 2019 coronavirus disease (COVID-19) is a contagious disease with certain potential for worldwide spread and potentially significant